Study of Ruxolitinib Cream in Children With Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

August 7, 2023

Study Completion Date

August 7, 2023

Conditions
Atopic Dermatitis
Interventions
DRUG

Ruxolitinib cream

Ruxolitinib 1.5% cream applied twice daily.

Trial Locations (15)

11375

Forest Hills Dermatology Group, Forest Hills

30328

Advanced Medical Research Pc, Sandy Springs

31406

Aeroallergy Research Lab of Savannah, Savannah

32746

Accel Clinical Research, Lake Mary

33014

San Marcus Research Clinic Inc., Miami Lakes

33021

Skin Care Research, Llc Scr Hollywood, Hollywood

33624

Forward Clinical Trials, Tampa

45414

Ohio Pediatric Research Association, Dayton

48326

Oakland Hills Dermatology Pc, Auburn Hills

71913

Burke Pharmaceutical Research, Hot Springs

78213

Progressive Clinical Research, San Antonio

85295

Desert Sky Dermatology, Gilbert

89509

Skin Cancer and Dermatology Institute, Reno

92801

Orange County Research Center, Anaheim

97030

Cyn3Rgy Research - Clinedge - Ppds, Gresham

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Innovaderm Research

UNKNOWN

lead

Incyte Corporation

INDUSTRY